(MedPage Today) — After just a few controversial months, Vinay Prasad, MD, MPH, has stepped down as director of FDA’s Center for Biologics Evaluation and Research (CBER).
His brief tenure was characterized by a public feud with Sarepta Therapeutics…
Source link : https://www.medpagetoday.com/washington-watch/fdageneral/116734
Author :
Publish date : 2025-07-30 13:00:00
Copyright for syndicated content belongs to the linked Source.
